Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma

European Journal of Surgical Oncology

Volumn 35, Issue 7, 2009, Pages 709-714

  Li, C ^a,b   Kim, S ^a,c   Lai, J F ^a,d   Oh, S J ^a   Hyung, W J ^a,c   Choi, W H ^a   Choi, S H ^a   Zhu, Z G ^b   Noh, S H ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c Cancer Metastasis Research Center   (South Korea)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Advanced gastric carcinoma; Lymph node dissection; Middle third; Splenic artery and hilum

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLEEN; SPLEEN ARTERY; SPLEEN PRESERVED LYMPHADENECTOMY; SPLENECTOMY; STOMACH CARCINOMA; SURVIVAL RATE; TUMOR VOLUME;

ABDOMEN; ADULT; AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; SPLEEN; SPLENIC ARTERY; STOMACH NEOPLASMS;

EID: 67349133918     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.03.011     Document Type: Article

References (23)

1. Shiu M.H., Papacristou D.N., Kosloff C., and Eliopoulos G. Selection of operative procedure for adenocarcinoma of the midstomach. Twenty years' experience with implications for future treatment strategy. Ann Surg 192 (1980) 730-737
2. Wu C.W., Hsieh M.C., Tsay S.H., Lui W.Y., and Peng F.K. Adenocarcinoma of midstomach. Clinical and pathoanatomic relation to lymph node metastases. J Clin Gastroenterol 19 (1994) 259-263
3. Ikeguchi M., and Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer. Am Surg 70 (2004) 645-648
4. Koga S., Kaibara N., Kimura O., Nishidoi H., and Kishimoto H. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer. Am J Surg 142 (1981) 546-550
5. Monig S.P., Collet P.H., Baldus S.E., et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol 76 (2001) 89-92
6. Qin H., and Lin C. Radical resection of gastric carcinoma with pancreas and spleen preservation and functional cleaning of lymph nodes. Chin Med J 115 (2002) 736-739
7. Maruyama K., Sasako M., Kinoshita T., Sano T., Katai H., and Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 19 (1995) 532-536
8. Roukos D.H. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol 6 (1999) 46-56
9. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1 (1998) 10-24
10. Yu W., Choi G.S., and Chung H.Y. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 93 (2006) 559-563
11. Zhang C.H., Zhan W.H., He Y.L., Chen C.Q., Huang M.J., and Cai S.R. Spleen preservation in radical surgery for gastric cardia cancer. Ann Surg Oncol 14 (2007) 1312-1319
12. International Union Against Carcinoma(UICC). In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumours. 5th ed. (1997), Wiley-Liss, New York
13. Bostanci E.B., Kayaalp C., Ozogul Y., Aydin C., Atalay F., and Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol 30 (2004) 20-25
14. Maeta M., Yamashiro H., Saito H., et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 125 (1999) 325-331
15. Bonenkamp J.J., Hermans J., Sasako M., et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
16. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501. J Clin Oncol 22 (2004) 2767-2773
17. Kulig J., Popiela T., Kolodziejczyk P., Sierzega M., Szczepanik A., and Polish Gastric Cancer Study Group. Standard D2 versus extended D2(D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193 (2007) 10-15
18. Griffith J.P., Sue-Ling H.M., Martin I., et al. Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36 (1995) 684-690
19. Takeuchi K., Tsuzuki Y., Ando T., et al. Total gastrectomy with distal pancreatectomy and splenectomy for advanced gastric cancer. J Surg Res 101 (2001) 196-201
20. Maruyama K., Okabayashi K., and Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11 (1987) 418-425
21. Lee K.Y., Noh S.H., Hyung W.J., et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol 8 (2001) 402-406
22. Otsuji E., Yamaguchi T., Sawai K., Okamoto K., and Takahashi T. Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer 79 (1999) 1789-1793
23. Kwon S.J. Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg 21 (1997) 837-844